Lea Roth

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.

Journal: Oncoimmunology

Published: March 06, 2023

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.

Journal: Cancers

Published: October 28, 2021

Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma.

Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma.

Journal: Cancers

Published: December 23, 2020

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma.

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma.

Journal: Cancers

Published: February 27, 2020

Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells.

Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells.

Journal: Frontiers in immunology

Published: January 31, 2020

Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor.

Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor.

Journal: International journal of molecular sciences

Published: July 05, 2019

IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.

IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.

Journal: International journal of molecular sciences

Published: May 09, 2019

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.

Journal: Oncotarget

Published: August 09, 2017

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: April 26, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026